BHC
BHC
CA0717341071
Bausch Health Companies Inc.
Loading chart...

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Latest News

Related stocks

PBH
PBH • United States
Prestige Consumer Healthcare In
48.23 USD
2.28B USD 1Y -24.4%
BCRX
BCRX • United States
BioCryst Pharmaceuticals, Inc.
8.55 USD
2.18B USD 1Y +13.9%
SUPN
SUPN • United States
Supernus Pharmaceuticals, Inc.
42.67 USD
2.48B USD 1Y -12.2%
LQDA
LQDA • United States
Liquidia Corporation
27.38 USD
2.45B USD 1Y +16.4%
PAHC
PAHC • United States
Phibro Animal Health Corporatio
38.3 USD
1.56B USD 1Y +0.8%
ANIP
ANIP • United States
ANI Pharmaceuticals, Inc.
73.89 USD
1.7B USD 1Y -21.5%
PCRX
PCRX • United States
Pacira BioSciences, Inc.
36.31 USD
1.45B USD 1Y +55.4%
XERS
XERS • United States
Xeris Biopharma Holdings, Inc.
10.48 USD
1.91B USD 1Y +24.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
62.6% p.a.
Max Drawdown (5Y)
-85.1%
Sharpe Ratio (5Y)
-0.46
Beta Factor
0.37
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (62.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -87.4% in the extended horizon.
ende